menu

Quintiles Library

Show Filters
Press Release
RESEARCH TRIANGLE PARK, NC - February 6, 1996 - Quintiles Transnational Corp. (Nasdaq:QTRN) announced today that it has signed a non-binding letter of intent to acquire 100% of the stock of PMC Contract Research AB located in Uppsala, Sweden. The proposed acquisition would expand Quintiles' ability to provide drug development services in Scandinavia and position the...
Read More
Press Release
MORRISVILLE, NC - November 7, 1995 - Quintiles Transnational Corp. (Nasdaq-NNM: QTRN) announced today the establishment of the Quintiles Emerging Companies Institute to offer small, specialized companies access to a full range of medical product development services and expert consultation. The Quintiles Emerging Companies Institute will provide customized product...
Read More
Press Release
RESEARCH TRIANGLE PARK, NC - March 6, 1995 - Quintiles Transnational Corp. (NASDAQ-NNM:QTRN) announced that a subsidiary, Quintiles Scotland Ltd., today completed agreements to acquire certain assets of a drug development facility located in Edinburgh, Scotland from Syntex Pharmaceuticals Limited, a member of the Roche group based in Basle, Switzerland. Quintiles...
Read More
Press Release
RESEARCH TRIANGLE PARK, NC - January 17, 1995 - Quintiles Transnational Corp. announced today that its subsidiary, Quintiles (UK ) Limited, has signed a non-binding letter of intent to acquire certain assets of a drug development facility from Syntex Pharmaceuticals Limited, a member of the Roche group in Basle, Switzerland. The facility is located in Edinburgh, Scotland....
Read More
Press Release
Research Triangle Park, NC, January 11, 1994 - In keeping with continued growth and expansion, Quintiles announces the following new appointments: Robert Adamski to Director, Clinical Operations, Quintiles Pacific, Inc. Prior to joining Quintiles, Mr. Adamski served as Midwest Clinical Research Manager with the R. W. Johnson Pharmaceutical Research Institute, a Johnson &...
Read More
Service
Reduce cost while enhancing value A risk-based approach to clinical monitoring can facilitate efficient trial delivery without compromising patient safety or data quality. You need a partner who understands the value risk-based monitoring provides and has the experience to execute your RBM trials. Integrated offerings deliver greater value Data-driven Trial Execution, is...
Read More
Service
A purely prospective approach to real-world research can result in long timelines and high costs – and still may not answer all of your questions. Our Outcome® software and Enriched studies integrate the wealth of existing healthcare data now available with primary data from physicians and patients, enriched prospective studies can to greatly increase the amount of...
Read More
Service
Maximize value while reducing risk Faced with longer timelines, low predictability, escalating costs and increasing regulatory demands, clinical trials are under intense pressure to succeed. Facilitate success with renewed confidence Quintiles combines clinical expertise and technology solutions to manage complex trials efficiently and effectively while helping to plan...
Read More
Service
Minimize risk by maximizing insight As drug development becomes increasingly expensive and time-consuming, you need expert insight to make the process more efficient and effective. By knowing the right answers to questions about dosing, patient populations and study design before you invest time and resources, you can determine the best course of action for your product...
Read More
Service
Uncover the critical evidence of success You’ve spent the millions of dollars to shepherd your product through development and you’ve gained market approval, but there’s more work to be done to increase the likelihood of long-term success. Stakeholders are demanding evidence to support regulatory, reimbursement and prescribing decisions. Staying ahead of competitors will...
Read More
Service
Go Beyond Regulatory Compliance Ensuring the success of established products goes beyond just meeting requirements. Amidst increasing regulatory complexity and growing stakeholder pressures to reduce costs, while driving revenue, there exists an opportunity to better align regulatory, safety and medical affairs to maximize product value. Enhance Value & Maximize...
Read More
Service
Proactively manage safety, quality and performance, with full visibility into your trial’s progress. Reporting & Oversight, powered by Quintiles Infosario®, gives you on-demand access to your study, program, and portfolio metrics in a dashboard view. This helps you uncover more accurate clinical and operational insights and make sure that you are on the right path in...
Read More
Service
Expedite cardiac safety with a streamlined process With a powerful combination of high performance ECG monitoring and drug development expertise, we bring together operational excellence, medical expertise and global reach to run superior cardiac safety studies and provide biopharma customers with accurate, actionable insights across the product development...
Read More
Service
Seeking answers You’re looking to answer complex biological questions through experimentation, without wasting valuable time. The methods and technologies available are numerous, and deciding on the right path can be a challenge. Find the optimum solutions Together we design the best fit. Quintiles and Expression Analysis (EA|Quintiles) joined forces in 2012. Together,...
Read More
Service
Predictable, on-time, lab data delivery Accuracy and efficiency in lab work are crucial, but you also need the value and insight that comes from close collaboration with a seasoned team of scientists and project managers, who understand the scientific and medical challenges of your protocol and can help you reach your goals on time and within budget. Worldwide...
Read More
Service
From database build to database lock, Quintiles is committed to customizing data management solutions that emphasize transparency, integrity and accountability as much as speed and accuracy. Our clinical data management team produces results that are source-verified, reproducible and cost-efficient. How do we set the standard for delivering data quality? Precision –...
Read More
Service
A solid infrastructure allows you to gear up or scale down Whether you’re just entering or phasing out of a market, in one region or in multiple countries, it’s critical to have a strong foundation in place so that you can target the right audiences, focus on appropriate stakeholders and anticipate challenges to ensure patients have access to innovative treatments....
Read More
Service
Transform drug development through data-driven design You want to maximize the value of your molecule, and, with so much at stake, your success depends on smarter program and trial designs. This requires transparent, rapid access to robust data to inform decision-making; objective scientific and operational expertise; a more structured, collaborative approach that...
Read More
Service
Our clinical monitoring teams deliver faster, more efficient investigator site support and data oversight Rigorous study-specific CRA preparation. Specialized therapeutic training. On-site in 80 countries, familiar with local customs and regulatory requirements. Streamline clinical monitoring with our Project Coordination Centers We often supplement regular...
Read More
Service
Develop the best evidence portfolio Peri- and post-approval, your product raises new questions for regulators, payers, providers and patients. As stakeholders seek evidence to support healthcare decisions, real world and late phase research becomes critical to the success of your product. New studies need to provide answers while factoring in emerging scientific standards...
Read More